These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6442225)

  • 1. The activity of natural killer cells in patients with rheumatoid arthritis: I. The effect of drugs used in vivo.
    Russell AS; Miller C
    Clin Exp Rheumatol; 1984; 2(3):227-9. PubMed ID: 6442225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of slow-acting antirheumatic drugs on blast formation of normal lymphocytes].
    Hamai T; Negishi M; Takahashi T
    Ryumachi; 1983 Aug; 23(4):193-201. PubMed ID: 6420896
    [No Abstract]   [Full Text] [Related]  

  • 3. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M; McCain GA; Orange JF
    J Rheumatol; 1985 Oct; 12(5):881-4. PubMed ID: 3936929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The anti-inflammatory effect of auranofin].
    Hiroi J; Ohara K; Fujitsu T; Hirai O; Satoh S; Ochi T; Senoh H; Mori J; Kikuchi H
    Nihon Yakurigaku Zasshi; 1985 Dec; 86(6):441-55. PubMed ID: 3937805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of auranofin on lymphocyte functions in vitro].
    Strejcek J; Jíra M; Horký J
    Cas Lek Cesk; 1985 Aug; 124(33):1045-7. PubMed ID: 3928163
    [No Abstract]   [Full Text] [Related]  

  • 9. The augmentation of human NK-cell activity by auranofin compared to interferon.
    Russell AS; Miller C
    Int J Immunopharmacol; 1984; 6(5):451-4. PubMed ID: 6209229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of auranofin and sodium aurothiomalate on peripheral blood monocytes.
    Scheinberg MA; Santos LM; Finkelstein AE
    J Rheumatol; 1982; 9(3):366-9. PubMed ID: 6288942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.
    Walz DT; DiMartino MJ; Griswold DE
    J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vivo effect of triethylphosphine gold (auranofin), sodium aurothiomalate and azathioprine on natural killer cell activity of patients with rheumatoid arthritis.
    Abom B; Pedersen BK
    Clin Exp Rheumatol; 1987; 5(1):47-52. PubMed ID: 3109798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possible mechanism of action of drugs in the basic therapy of rheumatoid arthritis: effect on platelet aggregation].
    Fioravanti A; Lolatte V; Giordano N; Frati E; Castagna ML; Morozzi G; Lalumera M; Marcolongo R
    Boll Soc Ital Biol Sper; 1984 May; 60(5):1051-6. PubMed ID: 6432005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M; Keown PA; Orange J
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of in vitro and in vivo effects of gold compounds on leukocyte function: possible mechanisms of action.
    Wolach B; DeBoard JE; Coates TD; Baehner RL; Boxer LA
    J Lab Clin Med; 1982 Jul; 100(1):37-44. PubMed ID: 6283001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E
    Med Clin (Barc); 1985 Jun; 85(2):73-9. PubMed ID: 3160899
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of gold compounds on function of phagocytic cells. Comparative inhibition of activated polymorphonuclear leukocytes and monocytes from rheumatoid arthritis and control subjects.
    Davis P; Johnston C
    Inflammation; 1986 Sep; 10(3):311-20. PubMed ID: 3017859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro boost of human NK activity by a triethylphosphine gold derivative.
    Russell AS; Nakashima S; Miller C
    Clin Exp Immunol; 1984 Jul; 57(1):207-10. PubMed ID: 6204799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of gold compounds on lymphocyte transformation and neutrophil chemotaxis--a comparison between sodium aurothiomalate and auranofin].
    Negishi M; Sato H; Sekine F; Ohno I; Kobayashi K; Ohseto Y; Hamai T; Takahashi T
    Ryumachi; 1983 Jun; 23(3):163-7. PubMed ID: 6414094
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.